Furthermore, AurA has been reported to be amplified or overexpressed in a number of cancer contexts, including colon, breast, and hematological cancers [39–43], where its expression corresponds with centrosome amplification [44–47]. Here, AURKA is linked to hematopoietic and lymphoid cell neoplasm.